BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38528272)

  • 21. Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma.
    Chen T; Xie G; Wang X; Fan J; Qiu Y; Zheng X; Qi X; Cao Y; Su M; Wang X; Xu LX; Yen Y; Liu P; Jia W
    Mol Cell Proteomics; 2011 Jul; 10(7):M110.004945. PubMed ID: 21518826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Omega-6-derived oxylipin changes in serum of patients with hepatitis B virus-related liver diseases.
    Lu Y; Fang J; Zou L; Cui L; Liang X; Lim SG; Dan YY; Ong CN
    Metabolomics; 2018 Jan; 14(3):26. PubMed ID: 30830341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pegbelfermin selectively reduces secondary bile acid concentrations in patients with non-alcoholic steatohepatitis.
    Luo Y; Decato BE; Charles ED; Shevell DE; McNaney C; Shipkova P; Apfel A; Tirucherai GS; Sanyal AJ
    JHEP Rep; 2022 Jan; 4(1):100392. PubMed ID: 34977519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 4210 Da and 1866 Da polypeptides as potential biomarkers of liver disease progression in hepatitis B virus patients.
    Ren Y; Yang L; Li M; Wang J; Yan H; Ma N; Liu W; Wang L; Gao X; Gao P; Li T; Liu D
    Sci Rep; 2021 Aug; 11(1):16982. PubMed ID: 34417517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening differential expression of serum proteins in AFP-negative HBV-related hepatocellular carcinoma using iTRAQ -MALDI-MS/MS.
    He X; Wang Y; Zhang W; Li H; Luo R; Zhou Y; Liao CL; Huang H; Lv X; Xie Z; He M
    Neoplasma; 2014; 61(1):17-26. PubMed ID: 24195504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of bile acid profile in plasma to differentiate cholangiocarcinoma from benign biliary diseases and healthy controls.
    Zhang X; Yang Z; Shi Z; Zhu Z; Li C; Du Z; Zhang Y; Wang Z; Jiao Z; Tian X; Zhang J; Zhai W; Kan Q
    J Steroid Biochem Mol Biol; 2021 Jan; 205():105775. PubMed ID: 33130021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inter-alpha-trypsin inhibitor heavy chain H4 as a diagnostic and prognostic indicator in patients with hepatitis B virus-associated hepatocellular carcinoma.
    Noh CK; Kim SS; Kim DK; Lee HY; Cho HJ; Yoon SY; Lee GH; Hyun SA; Kim YJ; Kim HJ; Hwang JA; Ahn SJ; Shin SJ; Lee KM; Yoo BM; Cho SW; Cheong JY
    Clin Biochem; 2014 Sep; 47(13-14):1257-61. PubMed ID: 24836184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LC-MS/MS method for the quantification of cortisol of hepatocellular carcinoma.
    Zhou Z; Li X; Yin S; Zhang Z; Li X; Miao X; Cheng H; Lou Y; Tu P; Lu Y; Zhang G
    Biomed Chromatogr; 2024 Apr; 38(4):e5829. PubMed ID: 38351664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NMR and LC/MS-based global metabolomics to identify serum biomarkers differentiating hepatocellular carcinoma from liver cirrhosis.
    Liu Y; Hong Z; Tan G; Dong X; Yang G; Zhao L; Chen X; Zhu Z; Lou Z; Qian B; Zhang G; Chai Y
    Int J Cancer; 2014 Aug; 135(3):658-68. PubMed ID: 24382646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abnormal bile acid-microbiota crosstalk promotes the development of hepatocellular carcinoma.
    Shen R; Ke L; Li Q; Dang X; Shen S; Shen J; Li S; Liang L; Peng B; Kuang M; Ma Y; Yang Z; Hua Y
    Hepatol Int; 2022 Apr; 16(2):396-411. PubMed ID: 35211843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum Bile Acids Are Associated with Pathological Progression of Hepatitis B-Induced Cirrhosis.
    Wang X; Xie G; Zhao A; Zheng X; Huang F; Wang Y; Yao C; Jia W; Liu P
    J Proteome Res; 2016 Apr; 15(4):1126-34. PubMed ID: 25964117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of serum AFP and DCP levels in the diagnosis of early-stage HBV-related HCC under different backgrounds.
    Song T; Wang L; Xin R; Zhang L; Tian Y
    J Int Med Res; 2020 Oct; 48(10):300060520969087. PubMed ID: 33135527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Large-scale, multicenter serum metabolite biomarker identification study for the early detection of hepatocellular carcinoma.
    Luo P; Yin P; Hua R; Tan Y; Li Z; Qiu G; Yin Z; Xie X; Wang X; Chen W; Zhou L; Wang X; Li Y; Chen H; Gao L; Lu X; Wu T; Wang H; Niu J; Xu G
    Hepatology; 2018 Feb; 67(2):662-675. PubMed ID: 28960374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Performance of Serum Alpha-Fetoprotein for Detecting Early-Stage Hepatocellular Carcinoma Is Influenced by Antiviral Therapy and Serum Aspartate Aminotransferase: A Study in a Large Cohort of Hepatitis B Virus-Infected Patients.
    Qian X; Liu Y; Wu F; Zhang S; Gong J; Nan Y; Hu B; Chen J; Zhao J; Chen X; Pan W; Dang S; Lu F
    Viruses; 2022 Jul; 14(8):. PubMed ID: 36016291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of serum Haptoglobin using glycoproteomics and lectin immunoassay in liver diseases in Hepatitis B virus infection.
    Dalal K; Dalal B; Bhatia S; Shukla A; Shankarkumar A
    Clin Chim Acta; 2019 Aug; 495():309-317. PubMed ID: 31014754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased levels of typically fetal bile acid species in patients with hepatocellular carcinoma.
    El-Mir MY; Badia MD; Luengo N; Monte MJ; Marin JJ
    Clin Sci (Lond); 2001 May; 100(5):499-508. PubMed ID: 11294690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The profile of bile acids and their sulfate metabolites in human urine and serum.
    Bathena SP; Mukherjee S; Olivera M; Alnouti Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Dec; 942-943():53-62. PubMed ID: 24212143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum Iron Levels Decreased in Patients with HBV-Related Hepatocellular Carcinoma, as a Risk Factor for the Prognosis of HBV-Related HCC.
    Wei Y; Ye W; Zhao W
    Front Physiol; 2018; 9():66. PubMed ID: 29467672
    [No Abstract]   [Full Text] [Related]  

  • 39. Dynamic Metabolomics Study of the Bile Acid Pathway During Perioperative Primary Hepatic Carcinoma Following Liver Transplantation.
    Sui W; Gan Q; Liu F; Ou M; Wang B; Liao S; Lai L; Chen H; Yang M; Dai Y
    Ann Transplant; 2020 Jun; 25():e921844. PubMed ID: 32572018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment outcomes after radiofrequency ablation in patients with non-B non-C hepatocellular carcinoma within Milan criteria: comparison with HBV-related hepatocellular carcinoma.
    Liu B; Tan Y; Shen H; Wang L; Huang G; Huang T; Long H; Xie X; Xie X
    Int J Hyperthermia; 2023; 40(1):2244207. PubMed ID: 37580046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.